Cargando…

Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

Detalles Bibliográficos
Autores principales: Le, Xiuning, Nadler, Eric, Costa, Daniel B., Heymach, John Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663239/
https://www.ncbi.nlm.nih.gov/pubmed/37891443
http://dx.doi.org/10.1007/s11523-023-01010-3
_version_ 1785138354683117568
author Le, Xiuning
Nadler, Eric
Costa, Daniel B.
Heymach, John Victor
author_facet Le, Xiuning
Nadler, Eric
Costa, Daniel B.
Heymach, John Victor
author_sort Le, Xiuning
collection PubMed
description
format Online
Article
Text
id pubmed-10663239
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-106632392023-10-27 Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast Le, Xiuning Nadler, Eric Costa, Daniel B. Heymach, John Victor Target Oncol Correction Springer International Publishing 2023-10-27 2023 /pmc/articles/PMC10663239/ /pubmed/37891443 http://dx.doi.org/10.1007/s11523-023-01010-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Le, Xiuning
Nadler, Eric
Costa, Daniel B.
Heymach, John Victor
Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_full Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_fullStr Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_full_unstemmed Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_short Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_sort correction to: egfr tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer harboring uncommon egfr mutations: a podcast
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663239/
https://www.ncbi.nlm.nih.gov/pubmed/37891443
http://dx.doi.org/10.1007/s11523-023-01010-3
work_keys_str_mv AT lexiuning correctiontoegfrtyrosinekinaseinhibitorsforthetreatmentofmetastaticnonsmallcelllungcancerharboringuncommonegfrmutationsapodcast
AT nadlereric correctiontoegfrtyrosinekinaseinhibitorsforthetreatmentofmetastaticnonsmallcelllungcancerharboringuncommonegfrmutationsapodcast
AT costadanielb correctiontoegfrtyrosinekinaseinhibitorsforthetreatmentofmetastaticnonsmallcelllungcancerharboringuncommonegfrmutationsapodcast
AT heymachjohnvictor correctiontoegfrtyrosinekinaseinhibitorsforthetreatmentofmetastaticnonsmallcelllungcancerharboringuncommonegfrmutationsapodcast